MGC Pharmaceuticals Limited
MGCLFOTCHealthcare
$0.27
+$0.01(+2.88%)
Market Cap$12112454
P/E Ratio—
52W High$5.1
52W Low$0.225
MGC Pharmaceuticals Limited (MGCLF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MGCLF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-06 | 2022-06 | 2021-06 | 2020-06 | 2019-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $3.39M | $4.73M | $3.00M | $2.08M | $0.66M |
| Cost of Revenue | $2.69M | $3.17M | $2.26M | $1.91M | $0.36M |
| Gross Profit | $1.29M | $1.56M | $0.74M | ($0.31M) | $0.30M |
| Gross Margin %(computed) | 37.96% | 33.01% | 24.58% | -14.72% | 45.65% |
| Operating Expenses | |||||
| R&D Expenses | $1.99M | $2.72M | $5.86M | $5.37M | $3.70M |
| G&A Expenses | $13.86M | $9.30M | $7.22M | $3.75M | $2.85M |
| Total Operating Expenses | $17.05M | $14.47M | $13.38M | $11.98M | $9.34M |
| Operating Income | ($15.49M) | ($15.50M) | ($11.94M) | ($11.80M) | ($8.71M) |
| Operating Margin %(computed) | -457.29% | -327.54% | -398.50% | -567.82% | — |
| Interest Income | $0.00M | $0.00M | $0.01M | $0.01M | $0.20M |
| Interest Expense | $0.26M | $0.21M | $0.37M | $0.14M | $0.00M |
| Income Before Tax | ($21.13M) | ($20.77M) | ($15.90M) | ($18.77M) | ($11.03M) |
| Income Tax Expense | $0.00M | ($0.42M) | ($0.54M) | ($0.43M) | $0.03M |
| Net Income | ($20.82M) | ($20.35M) | ($15.87M) | ($19.36M) | ($11.01M) |
| Net Margin %(computed) | -614.64% | -429.99% | -529.71% | -931.36% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-7.10 | $-7.90 | $-8.30 | $-14.00 | $-9.11 |
| Wtd Avg Shares | 2.95M | 2.57M | 1.91M | 1.38M | 1.21M |
| EBITDA | ($20.38M) | ($15.16M) | ($17.05M) | ($18.66M) | $0.88M |
| EBITDA Margin %(computed) | -601.57% | -320.37% | -569.13% | -897.62% | 134.22% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · AUD · M
Explore more MGC Pharmaceuticals Limited data
About MGC Pharmaceuticals Limited (MGCLF) Income Statement
MGC Pharmaceuticals Limited (MGCLF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, MGCLF reported revenue of $0.00B, gross profit of $0.00B (gross margin 37.96%), and net income of ($0.02B) — a net profit margin of -614.64%.
Frequently asked questions
MGCLF · 4 questionsMGC Pharmaceuticals Limited (MGCLF) reported revenue of $0.00B for 2023, down 28.4% year-over-year.
MGCLF revenueMGCLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08